NASDAQ: BRVE
Braveheart Bio Inc Stock Ownership - Who owns Braveheart Bio?

Insider buying vs selling

Have Braveheart Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michele A. AndersonCXO2026-08-071,111$18.00
$20.00kBuy
Forbion Growth Opportunities Fund III Cooperatief Ua10% Owner2026-08-071,920,000$18.00
$34.56MBuy
Forbion Growth Opportunities Fund III Cooperatief Ua10% Owner2026-08-071,680,000$18.00
$30.24MBuy
David Charles LubnerDirector2026-08-0755,555$18.00
$999.99kBuy
David I. MalekDirector2026-08-074,166$18.00
$74.99kBuy
Travis MurdochCEO;Pres2026-08-0783,333$18.00
$1.50MBuy
James Paul RickeyCFO2026-08-0727,777$18.00
$499.99kBuy
Christopher ViehbacherDirector2026-08-0783,333$18.00
$1.50MBuy

1 of 1

BRVE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BRVE insiders and whales buy or sell their stock.

BRVE Shareholders

What type of owners hold Braveheart Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Forbion Growth Opportunities Fund III Cooperatief Ua30.89%21,826,024$654.78MInsider
Travis Murdoch11.80%8,333,637$250.01MInsider
Erez Chimovits1.56%1,102,739$33.08MInsider
Orbimed Advisors LLC1.56%1,102,739$33.08MInsider
Jason V. Coloma1.56%1,100,456$33.01MInsider
David I. Malek1.43%1,013,297$30.40MInsider
Christopher Viehbacher1.08%759,857$22.80MInsider
James Paul Rickey1.00%703,575$21.11MInsider
Michele A. Anderson0.47%332,161$9.96MInsider
David Charles Lubner0.08%55,555$1.67MInsider

1 of 1

BRVE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABVC3.14%80.87%
ABVX63.37%0.00%
ACET28.27%71.73%Net Buying
ACXP4.23%59.85%
AARD46.75%46.87%Net Buying

Braveheart Bio Stock Ownership FAQ

Who owns Braveheart Bio?

Braveheart Bio (NASDAQ: BRVE) is owned by 0.00% institutional shareholders, 51.42% Braveheart Bio insiders, and 48.58% retail investors. Forbion Growth Opportunities Fund III Cooperatief Ua is the largest individual Braveheart Bio shareholder, owning 21.83M shares representing 30.89% of the company. Forbion Growth Opportunities Fund III Cooperatief Ua's Braveheart Bio shares are currently valued at $600.87M.

If you're new to stock investing, here's how to buy Braveheart Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.